Stocktoria
Nuo Therapeutics, Inc. AURX
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2017-01-19
Nuo Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 66.9% | 77.8% | 79.3% | 82.9% | — | — | 21.6% | 88.1% | -51.3% | 30.8% |
| Operating margin | -76.0% | -180.0% | -520.6% | -2958.2% | — | — | -663.0% | -109.8% | -2154.4% | -359.0% |
| Net margin | -75.8% | -170.2% | -521.2% | -2825.6% | — | — | -817.4% | -112.5% | -2077.4% | -458.8% |
| FCF margin | -34.4% | -174.8% | -521.8% | -3355.1% | — | — | -630.5% | — | — | -131.1% |
| Return on assets | -136.1% | -195.4% | -168.9% | -104.1% | -6.2% | -56.3% | -432.1% | -158.1% | -1051.8% | -746.5% |
| Return on equity | 262.6% | -452.3% | -305.2% | -144.7% | -11.4% | 18.0% | 98.8% | 1880.6% | -3102.0% | 144.5% |
| Debt / equity | — | — | — | — | 0.00× | — | — | — | — | — |
| Current ratio | 1.06 | 1.45 | 2.32 | 4.39 | 2.18 | 0.24 | 0.19 | 0.82 | 1.27 | 0.07 |
Source: SEC EDGAR filings · CIK 0001091596 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.